Appili Therapeutics Inc. (TSX:APLI)

Appili Therapeutics Revenue

In the fiscal year ending March 31, 2026, Appili Therapeutics had annual revenue of 244.18K CAD with 143.10% growth. Appili Therapeutics had revenue of 25.26K in the quarter ending March 31, 2026.

• Revenue: 244.18K
• Revenue Growth: +143.10%
• P/S Ratio: 8.13
• Revenue / Employee: 34.88K
• Employees: 7
• Market Cap: 1.99M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	244.18K	143.74K	143.10%
Mar 31, 2025	100.44K	-726.96K	-87.86%
Mar 31, 2024	827.41K	493.23K	147.60%
Mar 31, 2023	334.18K	-1.06M	-75.97%
Mar 31, 2022	1.39M	-	-
Mar 31, 2021	-	-	-
Mar 31, 2020	199.11K	-	-
Mar 31, 2019	-	-	-
Mar 31, 2018	-	-	-

Data Source: Fiscal.ai Last updated: Jun 27, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 18, 2026

Data Sources Report a data error